Sign In
Buy NKTR
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Biotech Stocks Blasts Off After Eczema Drug Trial
10:53am, Tuesday, 24'th Jun 2025
Biotech stock Nektar Therapeutics Inc (NASDAQ:NKTR) is soaring today, up 83.7% at $17.52 at last glance, after the company's eczema drug, rezpegaldesleukin, met its primary and secondary goals in a mi
Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial
07:35am, Tuesday, 24'th Jun 2025
Nektar Therapeutics said on Tuesday its experimental eczema drug had met the main goals of a mid-stage study.
Achieved statistical significance on primary endpoint at week 16 for mean percent change in EASI score from baseline for all rezpegaldesleukin arms versus placebo Achieved statistical significance fo
SAN FRANCISCO , June 23, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will
Nektar Therapeutics: 2 Data Readouts For REZPEG 2025 Could Establish Further POC
03:13pm, Wednesday, 11'th Jun 2025
Results from Nektar Therapeutics' phase 2b REZOLVE-AD study, using REZPEG for the treatment of patients with atopic dermatitis, are expected in June 2025. The global atopic dermatitis treatment market
AMBROSIA & NEKTAR Introduces Premium High-End Organic Food from Greece with a Commitment to Purity and Provenance
05:26pm, Tuesday, 10'th Jun 2025
Brand emphasizes absolute transparency and traceability, sourcing single-ingredient food from small artisan producers Brand emphasizes absolute transparency and traceability, sourcing single-ingredien
Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference
05:00pm, Tuesday, 13'th May 2025
SAN FRANCISCO , May 13, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual BioConnect Inv
Nektar Q1 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down
10:10am, Friday, 09'th May 2025
NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year.
Nektar Therapeutics (NKTR) Q1 2025 Earnings Call Transcript
10:08pm, Thursday, 08'th May 2025
Nektar Therapeutics (NASDAQ:NKTR ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Corinne Franklin – Investor Relations Howard Robin – President and Chief Executive O
Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates
07:25pm, Thursday, 08'th May 2025
Nektar Therapeutics (NKTR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.18 per share a year ago.
Nektar Therapeutics Reports First Quarter 2025 Financial Results
04:15pm, Thursday, 08'th May 2025
SAN FRANCISCO , May 8, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025. Cash and investments in marketable securiti
Nektar to Announce Financial Results for the First Quarter on Thursday, May 8, 2025, After Close of U.S.-Based Financial Markets
06:00pm, Thursday, 01'st May 2025
SAN FRANCISCO , May 1, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter on Thursday, May 8, 2025, after the close of U.S.-based financ
Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know
11:06am, Thursday, 01'st May 2025
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?
12:30pm, Friday, 11'th Apr 2025
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock?
Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
06:00pm, Thursday, 20'th Mar 2025
SAN FRANCISCO , March 20, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company will be webcasting its participation in the H.C. Wainwright 3rd Annual Autoimmune & I
